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Abstract
The term ‘whole person cancer care’ - an approach that addresses the needs of the 
person as well as treating the disease - is more widely understood in the UK than its 
synonym ‘integrative oncology”.  The National Health Service (NHS), provides free access to 
care for all, which makes it harder to prioritise NHS funding of whole person medicine, where 
interventions may be multi-modal and lacking in cost-effectiveness data.  Despite this, 
around 30% of cancer patients are known to use some form of complementary or alternative 
medicine (CAM). This is virtually never medically led, and usually without the support or 
even the knowledge of their oncology teams, with the exception of one or two large cancer 
centres. UK oncology services are, however, starting to be influenced from three sides; 
firstly, by well-developed and more holistic palliative care services; secondly, by directives 
from central government via the sustainable healthcare agenda; and thirdly, by increasing 
pressure from patient-led groups and cancer charities. CAM remains unlikely to be provided 
through the NHS, but nutrition, physical activity, mindfulness, and stress management are 
already becoming a core part of the NHS ‘Living With and Beyond Cancer’ agenda. This 
supports cancer survivors into stratified pathways of care, based on individual, self-reported 
holistic needs and risk assessments, which are shared between healthcare professionals 
and patients. Health and Wellbeing events are being built into cancer care pathways, 
designed to activate patients into self-management and support positive lifestyle change. 
Those with greater needs can be directed towards appropriate external providers, where 
many examples of innovative practice exist. These changes in policy and vision for the NHS 
present an opportunity for Integrative Oncology to develop further and to reach populations 
who would, in many other countries, remain underserved or hard-to-reach by whole person 
approaches.
Integrative Whole Person Oncology Care in the UK
Introduction
The term ‘whole person cancer care’ is more widely understood in the UK than its 
synonym ‘integrative oncology”. Whole person care describes an approach that addresses 
the needs of the person as well as treating the disease. This involves, for example, giving 
people the skills, therapeutic support and confidence they need to build their resilience and 
manage their symptoms, alongside treatments that help them live as well as possible, for as 
long as possible. Conventional oncology services are delivered alongside patient education 
and self-management programmes and are co-ordinated with supportive care that 
addresses psychological, emotional, and spiritual/existential needs. In this article we will 
review the key initiatives and policies that have facilitated the development of a whole 
person approach to cancer treatment in the UK. 
Mainstream medical provision in the UK is almost exclusively organised through the 
central government funded National Health Service (NHS). Hospitals and primary 
care/family physicians (General Practitioners, GPs) provide care that is bought by loco-
regional commissioning groups, and, in England, often directed by the National Institute of 
Health and Care Excellence (NICE). NICE assesses individual healthcare treatments and 
interventions for cost-effectiveness and declines re-imbursement if they fall below the NICE 
threshold of cost per quality adjusted life year (QALY) based on available research data (1). 
In cancer, some additional high-cost drugs not meeting the NICE cost/QALY metric, but 
deemed to meet certain efficacy criteria, are available through a separate funding structure, 
the Cancer Drugs Fund (CDF). There are downsides to this system that provides free 
access to care for all - it limits the availability of cancer treatments compared to some other 
countries, notably sections of the US and Germany, and it makes it harder to prioritise NHS 
funding of whole person medicine, where interventions may be multi-modal and currently 
lacking in cost-effectiveness data. This has led to the erosion of the few complementary 
medicine services that had been available on the NHS.  There has also been little in the way 
of support for academic institutions to research integrative approaches, despite some 
Department of Health investment in capacity building for CAM research in the early 2000s.  
While some University Departments of Community Medicine or Health Sciences continue to 
undertake small projects related to CAM, there is no co-ordinated or funded national 
programme of CAM research. Without this clinical and academic base, it has been more 
difficult to conduct and attract funding for the robust research studies on CAM therapies 
needed by NICE for its assessments.
How do people with cancer access complementary and alternative medicine?
Despite the threat to provision of CAM in the UK, around 30% of cancer patients are 
known to use some form of complementary therapy (2). This is virtually never medically led, 
and usually without the support or even the knowledge of their oncology teams.  There are 
one or two notable exceptions where large cancer centres have small departments of 
complementary therapy and contribute to the international research evidence base on CAM 
in cancer (3).  In the absence of a strong national body or guidance, the provision of CAM for 
people affected by cancer is largely provided privately or by voluntary sector (charitable) 
organisations and is somewhat fragmented. The palliative care sector is a clear case in 
point. The UK has a strong tradition in holistic palliative and end-of-life care for cancer 
patients, and its services are among the best in the world. Care is generally provided 
through independent charitable hospices, which receive some NHS staffing and funding and 
are supported by the NHS primary care services, as well as by palliative care teams within 
NHS hospitals. Within the NHS, there is no formal physician ownership of patients, financial 
or otherwise, allowing palliative care services to be available to patients alongside their 
normal oncological treatment from the point of diagnosis onwards. Despite this, the service 
provided is largely along traditional palliative care lines of complex symptom management 
and high quality end-of-life care. Although many hospices also offer some counselling, 
complementary therapies such as massage and reflexology, and respite care, these are 
usually more focussed on the patient at the end of the cancer journey rather than promoting 
whole person wellbeing.
Since the early 1980s, cancer charities have provided increasing amounts of informal 
support, information and complementary medicine (e.g. mindfulness, acupuncture, natural 
products) to various groups of cancer patients. Most (if not all) of these charities were 
started by people who had experienced cancer treatment themselves and saw the necessity 
for holistic approaches to care.  Examples include Penny Brohn UK, The Haven, Cavendish 
Cancer Care and Maggie’s Centres, to name a few. These charities actively seek to 
establish relationships with traditional medical oncology professionals. Penny Brohn UK is 
now working with the NHS and other partners to provide self-management education and 
complementary support for cancer patients around the UK, and there are now 19 Maggie’s 
Centres in NHS hospitals across the UK providing professional practical, emotional, and 
social support to people with cancer. The Haven also provides self-management education 
and complementary therapies for people with breast cancer, over multiple sites in England.
Key developments supporting whole person oncology care.
The development of closer relationships between the charity sector and NHS is in 
part due to the 2007 Cancer Reform Strategy (4) which, for the first time, outlined a national 
directive at improving the experience of cancer patients, rather than just improving medical 
outcomes. This was in part driven by Macmillan Cancer Support, a large national charity, 
which supports NHS cancer teams by funding clinical nurse specialists (CNS) and other 
patient support-worker posts. The national directive included better information sharing and 
continuity between primary care physicians and hospital-based medical services, improved 
face-to-face communication skills of oncologists, and enshrining the central role of the CNS 
as the patient advocate in the medical team. The National Cancer Survivorship Initiative 
(NCSI) was created to coordinate an extensive analysis of the unmet needs of cancer 
survivors (5). This work led to ‘well-being’ being recognised as a valid outcome in cancer 
medicine worth funding and a “Recovery Package” for all people with cancer being 
recommended. The Recovery Package includes access to: Holistic Needs Assessment and 
Care Planning, Treatment Summary, Cancer Care Review, and Health and Wellbeing 
Events (6). 
Concurrent to the development of this Recovery Package, was the development of a 
patient-reported outcome measure called Measure Yourself Concerns and Wellbeing 
(MYCaW), which provides an opportunity to quickly capture and track the severity of 
patients’ primary concerns in clinical consultations (7). MYCaW is now used in integrative 
oncology internationally. Data that directly reflects the patients’ voice, and therefore is fully 
patient-centred (as opposed to reflecting what professionals think the patient needs) has 
been used to support the development of interventions for people with cancer at a time when 
such interventions were being required for the Recovery Package. Such interventions have 
resulted in patients having increased knowledge, skills and confidence (“activation”) to 
improve their situation, which positively impacts on their health and their ability to sustain 
positive behaviour change. These factors enable improved health-related quality of life and 
improvements in concerns and wellbeing up to 12 months later (8). These data indicate high 
potential for long-term financial savings and clinically relevant improvement in outcomes.  
Moreover, the needs of carers and supporters can also be addressed through similar 
interventions. 
In 2014 the Government set out its vision of the NHS to meet new and current challenges in 
healthcare, which included a transformation of the NHS’ approach to living with and beyond 
cancer - by putting patient experience on a par with clinical effectiveness and safety, and 
placing more emphasis on prevention and greater control of patients over their own care, 
“including the option of shared budgets combining health and social care”(9).  An 
Independent Cancer Taskforce then reported on how to translate this vision into cancer 
services, highlighting that patient experience should be on a par with clinical effectiveness 
and safety, together with a “Transform[ed] … approach to support people living with and 
beyond cancer”(10).  An ancillary benefit is that supporting people into self-management and 
recovery, alongside regular screening investigations and rapid access to hospital review if 
there are symptoms or concerns, should create NHS savings by freeing up money currently 
spent on routine hospital-based follow up of asymptomatic patients. Furthermore, in 
England, there are now 44 strategic regions (STPs), with their own 5-year strategies on how 
budgets for health and social care are allocated.  This is facilitating the Government’s recent 
sustainable healthcare transformation agenda to promote self-management, person- and 
community-centred care, and ‘social prescribing’ (referring people from primary care into 
social or lifestyle support and self-management programmes as opposed to default 
prescribing of drugs). This strategic shift away from a one-size-fits-all approach to service 
provision and funding has provided an opportunity for some localities to fund CAM therapies 
as part of their social prescribing provision, rather than as part of their healthcare 
provision.   There is no centralized approach to do this, but STPs may bid to the Cancer 
Transformation Fund, (a short-term NHS based fund), in order to facilitate achieving this 
aspect of their STP strategy. Funds may, for example, come from the public health budgets, 
the primary care budgets, local authority budgets or a combination of these depending on 
the strategy for each STP region.  
In 2012, The British Society of Integrative Oncology (BSIO) was established, along 
the lines of the international Society of Integrative Oncology, as a multidisciplinary 
organisation. It recognises the increased patient demand for whole person care, as well as 
the current lack of involvement of the oncology care team in complementary therapy 
decisions, and therefore the potential for increased risks of unintended adverse effects and 
interactions. The BSIO therefore promotes balanced discussion between healthcare 
professionals, complementary medicine practitioners and researchers, about the evidence 
for CAM within the provision of whole person cancer care.  
Conclusion
UK oncology services are starting to be influenced from three sides; firstly, by well-
developed and more holistic palliative care services; secondly, by directives from central 
government via the sustainable healthcare agenda; and thirdly, by increasing pressure from 
patient-led groups and cancer charities. Within the NHS, the focus remains on supporting 
cancer survivors into stratified pathways of care, based on individual, self-reported holistic 
needs and risk assessments, which are shared between healthcare professionals and 
patients. Unmet needs can then be addressed via the Recovery Package’s Health and 
Wellbeing events, which are built into cancer care pathways, designed to activate patients 
into self-management and support positive lifestyle change. Those with greater needs can 
be directed towards appropriate providers external to the NHS, where many examples of 
innovative practice exist. CAM remains unlikely to be provided through the NHS, but 
nutrition, physical activity, mindfulness, and stress management are already becoming a 
core part of the NHS ‘Living With and Beyond Cancer’ agenda.
A cancer diagnosis provides a unique, “teachable moment”(11), where people are 
often highly motivated to make positive lifestyle changes that they might not have 
considered before. The national public healthcare system in the UK, through national 
guidelines, government directives and working alongside the UK’s influential national 
voluntary (not-for-profit) sector presents an opportunity for Integrative Oncology to develop 
further and to reach populations who would, in many other countries, remain underserved or 
hard-to-reach by whole person approaches.
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